Targeting the vascular endothelial growth factor (VEGF) has shown benefits in the treatment of cervical cancer [5], and immunotherapy presents an additional rational approach for the treatment of cervical cancer given the molecular underpinnings of this HPV-related disease [6]. This evidence concerns the gene VEGFA and cervical carcinoma.